Table 2. Effects favor ABBT at 1-, 3-, and, 9-Month Follow-Ups.

	Mean Change
Month 1 - Baseline	TAU (n = 13)	AABT (n = 15)	Cohen's d (95%CI)
Experiential avoidance of HIV	-1.62 (10.1)	-6.20 (15.2)	-.35 (-1.10; 0.40)
HIV Disclosure willingness	1.08 (3.25)	2.00 (6.12)	.18 (-0.56; 0.92)
# of HIV Disclosures	0.04 (0.18)	0.24 (0.28)	.84 (0.06; 1.61)
Perceived social support	-.30 (1.29)	0.25 (1.27)	.43 (0.32; 1.18)
Month 3 - Baseline	(n = 12)	(n = 15)
Experiential avoidance of HIV	-0.17 (12.8)	-7.87 (13.1)	-.59 (-1.36; 0.19)
HIV Disclosure willingness	1.25 (3.60)	4.00 (6.22)	.53 (-0.25; 1.29)
# of HIV Disclosures	0.10 (0.32)	0.29 (0.33)	.58 (-0.20; 1.35)
Perceived social support	0.17 (0.93)	0.54 (1.14)	.35 (0.42; 1.11)
Month 9 - Baseline	(n = 13)	(n = 14)
Experiential avoidance of HIV	-1.85 (11.20)	-7.07 (12.3)	-.44 (-1.20; 0.33)
HIV Disclosure willingness	2.38 (4.91)	3.14 (6.65)	.13 (-0.62; 0.88)
# of HIV disclosures	0.18 (0.42)	0.30 (0.33)	.32 (-0.44; 0.48)
Perceived social support	0.00 (1.50)	0.40 (1.22)	.29 (0.47; 1.05)